DrugPatentWatch Database Preview
Taro Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?
TARO PHARMS has fifteen approved drugs.
There are four US patents protecting TARO PHARMS drugs.
There are ten patent family members on TARO PHARMS drugs in seven countries and thirty supplementary protection certificates in twelve countries.
Summary for Taro Pharms
| International Patents: | 10 |
| US Patents: | 4 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 15 |
Drugs and US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms | NAFTIFINE HYDROCHLORIDE | naftifine hydrochloride | CREAM;TOPICAL | 205975-001 | Sep 8, 2016 | RX | No | Yes | Start Trial | Start Trial | |||||
| Taro Pharms | TAZAROTENE | tazarotene | CREAM;TOPICAL | 208258-001 | Apr 3, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | OXICONAZOLE NITRATE | oxiconazole nitrate | CREAM;TOPICAL | 205076-001 | Mar 7, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | TRETINOIN | tretinoin | CREAM;TOPICAL | 211644-001 | Jan 25, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | Start Trial |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | Start Trial |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2523660 | Start Trial |
| Canada | 2822220 | Start Trial |
| Canada | 2609579 | Start Trial |
| China | 102834096 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0186118 | SPC/GB05/029 | United Kingdom | Start Trial | PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218 |
| 0284288 | SPC/GB98/002 | United Kingdom | Start Trial | PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730 |
| 1458369 | SPC/GB10/005 | United Kingdom | Start Trial | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
| 1304992 | 132013902214376 | Italy | Start Trial | PRODUCT NAME: CLINDAMICINA FOSFATO E TRETINOINA(ACNATAC); AUTHORISATION NUMBER(S) AND DATE(S): PA1332/043/001, 20130322;042056010/M - 022/M, 20130718 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
